why choose us

300×250 Ad Slot

Research Article: m6A-modified circARHGAP12 promotes the aerobic glycolysis of doxorubicin-resistance osteosarcoma by targeting c-Myc

Date Published: 2024-01-04

Introduction:
Osteosarcoma (OS) is characterized by the most frequent primary solid malignancy in bone, with exceptional high incidence in young individuals or children [1, 2]. Despite the great improvements of OS therapeutic methods, including surgery incorporated with chemoradiotherapy [3], the five-year OS survival rate is approximate 70% (for localized type) and approximate 30% (recurrent/metastatic type) [4]. Thus, a better accurate target and novel understanding of OS molecular mechanism is critical for OS therapeutic…

Read more

300×250 Ad Slot